We collect cookies to analyze our website traffic and performance; we never collect any personal data.Cookies Policy
Accept
Michigan Post
Search
  • Home
  • Trending
  • Michigan
  • World
  • Politics
  • Top Story
  • Business
    • Business
    • Economics
    • Real Estate
    • Startups
    • Autos
    • Crypto & Web 3
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Beauty
    • Art & Books
  • Health
  • Sports
  • Entertainment
  • Education
Reading: Starting later this week, some at-risk Americans become eligible for a 4th Covid shot.
Share
Font ResizerAa
Michigan PostMichigan Post
Search
  • Home
  • Trending
  • Michigan
  • World
  • Politics
  • Top Story
  • Business
    • Business
    • Economics
    • Real Estate
    • Startups
    • Autos
    • Crypto & Web 3
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Beauty
    • Art & Books
  • Health
  • Sports
  • Entertainment
  • Education
© 2024 | The Michigan Post | All Rights Reserved.
Michigan Post > Blog > Trending > Starting later this week, some at-risk Americans become eligible for a 4th Covid shot.
Trending

Starting later this week, some at-risk Americans become eligible for a 4th Covid shot.

By Editorial Board Published January 10, 2022 4 Min Read
Share
Starting later this week, some at-risk Americans become eligible for a 4th Covid shot.
09virus briefing immuncompromised4thdose 01 facebookJumbo

Some people with a weakened immune system can get a fourth dose of the coronavirus vaccine as early as this coming week, according to recommendations from the Centers for Disease Control and Prevention that were updated last week.

The C.D.C. endorsed a third dose of the Pfizer-BioNTech and Moderna vaccines for moderately or severely immunocompromised people on Aug. 13, but said this would be considered a part of the primary immunization, not a booster shot.

In October, the agency said those immunocompromised people could receive a booster shot — a fourth dose of vaccine, six months after their third dose. These guidelines were consistent with its recommendation for other adults.

Last week, hoping to stem the surge of infections with the highly contagious Omicron variant, the C.D.C. shortened that interval to five months for a booster shot for Pfizer-BioNTech or Moderna recipients.

For immunocompromised people who received a single shot of the coronavirus vaccine made by Johnson & Johnson, the C.D.C. does not recommend additional primary doses, but advises that they get a booster shot of the Moderna or Pfizer-BioNTech vaccines two months after the first dose.

Some people are born with absent or faulty immune systems, and in others, treatments for some diseases like cancer diminish the potency of immune defenses. The C.D.C. estimates there are about seven million immunocompromised individuals in the country.

Many of them produce few to no antibodies in response to a vaccine or an infection, leaving them susceptible to the virus. When they do become infected, they may suffer prolonged illness, with death rates as high as 55 percent.

It is unclear what proportion of those people are protected by additional doses. Still, with the Omicron variant surging in the country, some immunocompromised people sought out fourth or even fifth shots of the vaccines even before the C.D.C. changed its guidelines. While receiving multiple doses of vaccines in a short period is unlikely to be harmful, it may produce diminishing returns, according to some experts.

The C.D.C. has said that any American 12 and older can receive a Pfizer-BioNTech booster — those 18 and older can alternatively receive a Moderna booster — five months after completing their initial shots with those vaccines. Israel has already begun offering fourth doses to high-risk groups including older adults. But the Biden administration has not yet said whether it plans to follow suit.

When asked on Friday about the possibility of a fourth shot for the general population, Dr. Rochelle Walensky, director of the C.D.C., said that focus remained on Americans eligible for their third shots.

She added that U.S. officials remained in close touch with Israel experts about their data. “We will be following our own data carefully as well, to see how these boosters are working in terms of waning effectiveness, not just for infection but, importantly, for severe disease,” she said.

TAGGED:BioNTech SECenters for Disease Control and PreventionCoronavirus (2019-nCoV)Coronavirus Omicron VariantImmune SystemModerna IncPfizer IncThe Washington MailUnited StatesVaccination and Immunization
Share This Article
Facebook Twitter Email Copy Link Print

HOT NEWS

New MSTR ETF gives weekly payouts — till BTC market turns

New MSTR ETF gives weekly payouts — till BTC market turns

Crypto & Web 3
July 15, 2025
AG Nessel urges Congress to 'curb unscrupulous' ICE techniques

AG Nessel urges Congress to 'curb unscrupulous' ICE techniques

LANSING, Mich. (WLNS) — Michigan Lawyer Basic Dana Nessel is co-leading a coalition of attorneys…

July 15, 2025
Registrar Computershare amongst suitors for former fintech star PrimaryBid

Registrar Computershare amongst suitors for former fintech star PrimaryBid

The Australian-listed share registrar Computershare is amongst a pack of suitors circling PrimaryBid, one of…

July 15, 2025
Coinbase spends k per day to guard Brian Armstrong from tequila

Coinbase spends $17k per day to guard Brian Armstrong from tequila

Coinbase is spending over $6 million yearly on Brian Armstrong’s private safety, which regardless of…

July 15, 2025
Lawsuit: Grand Rapids lady discovered lifeless mouse in Monster Power drink

Lawsuit: Grand Rapids lady discovered lifeless mouse in Monster Power drink

GRAND RAPIDS, Mich. (WOOD) — A Grand Rapids resident is suing Monster Beverage Company, alleging…

July 15, 2025

YOU MAY ALSO LIKE

The Quiet Strength of Brenda’s Verse: A Journey Through Poetry and Faith

In a world that often feels like it’s moving too fast, Brenda Sanders, a 69-year-old poet from New York, offers…

Art & BooksTrending
July 12, 2025

“A Family’s Fight to Reclaim Their Legacy”

Introduction: For generations, the Wright family has worked and lived on their land in Phillips County, Arkansas. But a battle…

Trending
July 9, 2025

Streamline, Scale, Succeed: Why Global Enterprises Are Moving to Odoo ERP

Introduction Global businesses face a growing need for centralized, scalable systems. Many still rely on disconnected software tools for operations,…

Tech / ScienceTrending
June 27, 2025

Beloved Children’s Book 𝑻𝒉𝒆 𝑴𝒂𝒑 𝑴𝒚 𝑴𝒐𝒎𝒔 𝑮𝒂𝒗𝒆 𝑴𝒆 Returns to Best-Seller Status Years After Its Release — and Fans Are Begging for More

Years after its quiet but powerful debut, "The Map My Moms Gave Me" has reclaimed the spotlight — this time…

Art & BooksTrending
June 23, 2025

Welcome to Michigan Post, an esteemed publication of the Enspirers News Group. As a beacon of excellence in journalism, Michigan Post is committed to delivering unfiltered and comprehensive news coverage on World News, Politics, Business, Tech, and beyond.

Company

  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement

Contact Us

  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability

Term of Use

  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices

© 2024 | The Michigan Post | All Rights Reserved

Welcome Back!

Sign in to your account

Lost your password?